QRG CAPITAL MANAGEMENT, INC.

Position in INVA — Innoviva, Inc.

CIK 1996454 BERWYN, PA

Position in INVA

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$2,697,198

+$336,652 QoQ

Shares Held

118,767

+17.2% QoQ

Ownership

0.161%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 12 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $32,600,934 across 24 Biotechnology names. INVA ranks #2 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	21,665	$10,761,655
2	INVA	Innoviva, Inc. This page	118,767	$2,697,198
3	PTCT	Ptc Therapeutics, Inc.	24,989	$2,038,352
4	GMAB	Genmab A/S	72,643	$1,995,503
5	ARGX	Argenx SE	1,907	$1,769,257
6	RVMD	Revolution Medicines, Inc.	8,083	$1,513,784
7	INCY	Incyte Corp	13,350	$1,513,356
8	MRNA	Moderna, Inc.	15,957	$1,117,468

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,697,198	118,767	+17.2%	Shares	Sole	2026-07-14
2026-03-31	$2,360,546	101,311	+27.1%	Shares	Sole	2026-04-27
2025-12-31	$1,593,282	79,704	-0.8%	Shares	Sole	2026-02-02
2025-09-30	$1,466,971	80,382	-28.5%	Shares	Sole	2025-10-28
2025-06-30	$2,259,421	112,465	+16.5%	Shares	Sole	2025-07-21
2025-03-31	$1,749,853	96,517	+7.6%	Shares	Sole	2025-04-17
2024-12-31	$1,556,451	89,709	+4.4%	Shares	Sole	2025-02-05
2024-09-30	$1,659,501	85,940	+13.1%	Shares	Sole	2024-10-30
2024-06-30	$1,246,564	76,010	+19.7%	Shares	Sole	2024-07-12
2024-03-31	$967,709	63,498	+9.5%	Shares	Sole	2024-05-07
2023-12-31	$930,544	58,014	+3.1%	Shares	Sole	2024-02-07
2023-09-30	$730,596	56,243	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.